| Titre |
A Comprehensive and Observational Myeloproliferative
Neoplasms (MPN) Registry in the Province of Quebec |
| Protocole ID |
Registre des NMP (CINC424BCA04T) |
| ClinicalTrials.gov ID |
|
| Type(s) de cancer |
NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide |
| Phase |
Autres |
| Institution |
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
 PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
5415 boul. de l'Assomption, Montréal, QC, H1T2M4
|
| Ville |
Montréal |
| Investigateur(trice) principal(e) |
Dr Lambert Busque
|
| Coordonnateur(trice) |
Michel-Olivier Gratton
514-252-3400 poste 2397
|
| Statut |
 Actif en recrutement |
| Critètes d'éligibilité |
All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
- Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
- Are 18 years of age or older;
- Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
| Critètes d'exclusion |
Patients who meet any of the following criteria will be excluded from participation:
- Life expectancy of less than 3 months for a condition not related to MPN;
- Patients suffering of CML.
|
Groupe d'étude en oncologie du Québec